Immunocore and Argenx Among Fast-Track Hopefuls At EMA
Five Accelerated Assessment Decisions Due, Including On Tebentafusp And Efgartigimod
EU reviewers will decide this week whether to grant accelerated assessment to a handful of new dug candidates that will soon be filed for approval.
